|

HTL0039732 Capsules and atezolizumab infusion Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Cancer Research UK1

Indications

  • Pheochromocytomas1
  • Kidney Neoplasms1
  • Prostatic Neoplasms, Castration-Resistant1
  • Urinary Bladder Neoplasms1
  • Esophageal Neoplasms1

Other1 trial

HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.